Catherine Mathis
Clinical science
TX CELL
France
Biography
Catherine Mathis, 50, is appointed VP Regulatory Affairs. Catherine has more than 25 years’ experience working in clinical research and regulatory affairs with pharma and biotech companies, including in the areas of immunology and oncology. Specifically, she developed the strategies of innovative healthcare products from Phase 1 to phase 3 studies with an excellent product knowledge concerning US and EU regulations. She conducted many regulatory processes with interactions with the US FDA and the European health authorities (EMA and national competent authorities). It has also included interactions with European payers (HTA bodies). She acquired expertise in the regulation of personalized medicine by developing companion diagnostic assays associated with innovative immunotherapy products. Prior to joining TxCell in 2015, Catherine served as a senior director, for Voisin Consulting the international consulting company.
Research Interest
Clinical science
